- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01668602
Stroke Gait Rehabilitation Using Functional Electrical Stimulation
Cortical and Spinal Correlates of Post-stroke Gait Rehabilitation
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Stroke is the number one cause of disability. Difficulty with walking affects most stroke survivors. Walking deficits (e.g. reduced ankle flexion during swing phase, decreased forward propulsion during terminal stance) can cause risks of falls, slow walking speed, increased effort of walking, and difficulties with activities of daily living. Restoration of walking ability can improve quality of life, and is perceived as a major goal of rehabilitation by stroke survivors. Examples of interventions that are used to rehabilitate walking post-stroke are functional electrical stimulation, fast treadmill walking, and bio- feedback. While recent research has focused on comparing the effectiveness of different gait rehabilitation interventions, the neural and biomechanical mechanisms underlying different gait rehabilitation strategies are unknown. FastFES is a novel gait training intervention that combines the beneficial effects of two independent interventions: Fast treadmill walking and FES. The FastFES intervention incorporates principles of physiology, biomechanics, motor control and learning, and predictions of forward-dynamic gait simulations to improve post-stroke gait.
The overall purpose of this protocol is to assess the biomechanical and neurophysiologic effects of rehabilitative strategies and protocols that are commonly used during physical therapy treatment of gait disorders post-stroke among two cohorts of people. Aim 1 of the study will assess the changes in gait biomechanics, corticospinal excitability, and walking function during 18 sessions of gait retraining, with participants in Cohort 1. Aim 2 of the study assesses the effect of parameters such as walking speed (slow, fast, variable, split-belt walking), functional electrical stimulation parameters (short-term changes induced by fast versus FastFES, stimulation intensity, number of muscles stimulated), and bio-feedback on within-session changes in gait biomechanics, walking function, and corticospinal excitability, among participants in Cohort 2.
Within Cohort 1, participants will receive identical treatment throughout the 18 training sessions (i.e. FastFES training). Within Cohort 2, participants will participate in 3 training sessions of both FastFES and fast walking training, with a 3-week break between the two types of training.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30322
- Emory University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Chronic stroke (>6 months post stroke)
- First (single) lesion
- Able to walk with or without the use of a cane or walker
- Sufficient cardiovascular health and ankle stability to walk for 6 minutes at a self-selected speed without an orthoses
- Resting heart rate 40-100 beats per minute
- Resting blood pressure between 90/60-70/90
Exclusion Criteria:
- Evidence of moderate/ severe chronic white matter disease or cerebellar stroke on MRI
- Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements
- Insulin dependent diabetes
- History of lower extremity joint replacement
- Score of >1 on question 1b and >0 on question 1c on NIH Stroke Scale
- Inability to communicate with investigators
- Neglect/hemianopia, or unexplained dizziness in last 6 months
- Neurologic conditions other than stroke
- Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking
- Contraindications to transcranial magnetic stimulation (TMS) are: history of seizures, metal implants in the head or face, history of recurring or severe headaches/migraine, headache within the past 24 hours, presence of skull abnormalities or fractures, hemorrhagic stroke, history of dizziness, syncope, nausea, or loss of consciousness in the past 12 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Cohort 1 - FastFES Training
Participants with chronic stroke in Cohort 1 will receive 18 training sessions of FastFES (fast treadmill walking with electrical stimulation).
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Otros nombres:
|
Experimental: Cohort 2 - FastFES and Fast Walking
Participants with chronic stroke in Cohort 2 who complete 3 sessions of FastFES and 3 sessions of fast walking.
|
Functional electrical stimulation (FES) is a technique that causes a muscle to contract through the use of an electrical current.
The therapist applies an electrical current to either the skin over the nerve, or over the bulk of the muscle, and this will cause a muscle contraction.
The FES is delivered to 2 muscle groups (dorsiflexor and plantarflexor) timed appropriately with the gait cycle.
FastFES gait training sessions may comprise up to six 6-minute bouts of walking with rest breaks between bouts (total 30-minutes of walking).
The last training bout (bout 6) may comprise 6-minutes of over ground walking, during which subjects will be asked to walk as fast as they can.
For safety, a physical therapist will walk with and guard the subject during over ground walking.
Otros nombres:
Fast walking training sessions will be similar to FastFES in duration, dosage, structure but no FES will be provided.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Periodo de tiempo: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in MEP amplitude (transverse abdominal (TA) muscle) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Periodo de tiempo: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES After 18 Training Sessions in Cohort 1
Periodo de tiempo: Baseline and up to 6 weeks
|
Change from baseline in MEP amplitude (TA muscle in a resting state) is used as a measure of corticospinal excitability that is assessed using a non-invasive technique called transcranial magnetic stimulation (TMS).
Electrical activity from muscles in response to the TMS will be collected using surface electromyography (EMG) sensors attached to muscles that play critical roles during FastFES versus Fast walking.
TMS will be delivered using two Magstim 200 stimulators connected via a BiStim module.
An average of 10 TMS-evoked MEP responses will be used to comparing mean peak-to-peak MEP amplitudes in response to suprathreshold TMS delivered to the hotspot.
|
Baseline and up to 6 weeks
|
Change in H-Reflex /M-Wave (Hmax/Mmax) Ratio Among FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Periodo de tiempo: Baseline and up to 6 weeks
|
Change from baseline in (Hmax/Mmax) ratio is used as a measure of spinal reflex excitability, that is assessed using peripheral electrical stimulation delivered to the nerves innervating the ankle muscles.
An electrical stimulation electrode is placed just above the knee, and used as the anode for tibial nerve stimulation.
Electrical stimulation is delivered via surface electrodes in a static position to the popliteal fossa.
The subject's EMG activity will be recorded while the cathode is moved at the back of the knee to determine the location that provides the best EMG response (H-reflex).
EMG activity will be recorded while 50-60 electrical stimuli (short 1 ms square pulses, ranging in intensity in milliAmpere(mA) 1-80), 7-10 seconds apart, are delivered to the muscle.
Also 5-20 electrical stimulus pulses at intensities are delivered that elicit a percentage of the maximum reflex response.
|
Baseline and up to 6 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2
Periodo de tiempo: Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline, week 3 (after 3 sessions of one intervention), week 6 (after 3 sessions of the other intervention)
|
Change in Peak Anterior Ground Reaction Force (AGRF) of FastFES Versus Fast Walking After 18 Training Sessions in Cohort 1
Periodo de tiempo: Baseline and up to 6 weeks
|
Change from baseline in peak AGRF during treadmill walking will be collected using a treadmill instrumented with two force platforms under each belt.
Motion analysis data will be collected during 15- to 40-second long dynamic walking trials as subjects walk on a treadmill.
|
Baseline and up to 6 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Trisha Kesar, PT, PhD, Emory University
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IRB00058363
- 5K01HD079584-02 (Subvención/contrato del NIH de EE. UU.)
- 13SDG13320000 (Otro identificador: American Heart Association)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Accidente cerebrovascular
-
University of CalgaryThe George Institute for Global Health, AustraliaAún no reclutandoAccidente cerebrovascular isquémico agudo AIS | Accidente cerebrovascular, agudo, accidente cerebrovascular isquémico | Accidente cerebrovascular agudoCanadá, Australia
-
WandercraftReclutamientoTrastornos cerebrovasculares | Apoplejía Isquémica | Accidente cerebrovascular agudo | Accidente cerebrovascular hemorrágico | Hemiparesia | Accidente cerebrovascular | Hemiparesia;Posterior al accidente cerebrovascular/ACV | Accidente cerebrovascular subagudo | Hemiparesia/hemiplejía (debilidad/parálisis...Alemania, Francia, España
-
Dr. med. Carlo CeredaEnte Ospedaliero Cantonale, BellinzonaTerminadoEnfermedad cerebrovascular, accidente cerebrovascular isquémicoSuiza
-
BayerTerminado
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Terminado
-
University of Wisconsin, MadisonNational Institutes of Health (NIH)Terminado
-
Palacky UniversityČeské Budějovice HospitalDesconocidoCirculación cerebrovascularChequia
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminadoCirculación cerebrovascularPaíses Bajos
-
Medical University of ViennaTerminadoCirculación cerebrovascularAustria
-
University of Missouri-ColumbiaReclutamientoCirculación cerebrovascularEstados Unidos